These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 401123)

  • 21. Importance of CEA and CA 15-3 during disease progression in metastatic breast cancer patients.
    Laessig D; Nagel D; Heinemann V; Untch M; Kahlert S; Bauerfeind I; Stieber P
    Anticancer Res; 2007; 27(4A):1963-8. PubMed ID: 17649806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The biochemistry of cyst fluids.
    Miller WR
    Br J Clin Pract Suppl; 1989 Nov; 68():94-9; discussion 111-5. PubMed ID: 2488573
    [No Abstract]   [Full Text] [Related]  

  • 23. Progesterone-binding cyst protein in human breast tumor cytosol.
    Lea OA; Kvinnsland S; Thorsen T
    Cancer Res; 1987 Dec; 47(23):6189-92. PubMed ID: 3677070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural study of GCDFP-15/gp17 in disease versus physiological conditions using a proteomic approach.
    Caputo E; Camarca A; Moharram R; Tornatore P; Thatcher B; Guardiola J; Martin BM
    Biochemistry; 2003 May; 42(20):6169-78. PubMed ID: 12755619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer metastatic to the eyelids.
    Claessens N; Rakic L; Arrese JE; Pierard GE
    Eur J Dermatol; 2000 Aug; 10(6):473-4. PubMed ID: 10980473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor associated markers in breast cancer.
    Franchimont P; Zangerle PF; Colin C; Osterrieth P; Hendrick JC; van Cauwenberge JR; Hustin J
    Eur J Cancer (1965); 1980; Suppl 1():17-20. PubMed ID: 6172278
    [No Abstract]   [Full Text] [Related]  

  • 27. Carcinoembryonic antigen: an invaluable marker for advanced breast cancer.
    Pathak KA; Khanna R; Khanna HD; Khanna S; Gupta S; Khanna NN
    J Postgrad Med; 1996; 42(3):68-71. PubMed ID: 9715319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gross cystic disease fluid protein-15 in salivary gland tumors.
    Swanson PE; Pettinato G; Lillemoe TJ; Wick MR
    Arch Pathol Lab Med; 1991 Feb; 115(2):158-63. PubMed ID: 1992983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical value of TPS, CEA and CA 15-3 in breast cancer patients.
    Blijlevens NM; Oosterhuis WP; Oosten HR; Mulder NH
    Anticancer Res; 1995; 15(6B):2711-6. PubMed ID: 8669851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tamoxifen in breast cancer.
    Anand A
    Hosp Pract (Off Ed); 1993 Jun; 28(6):17. PubMed ID: 8509477
    [No Abstract]   [Full Text] [Related]  

  • 31. Monoclonal antibody B72.3 immunostaining of breast carcinoma. Patterns of staining and relationship to mucin content and GCDFP-15 reactivity.
    Soomro S; Shousha S
    Arch Pathol Lab Med; 1992 Jan; 116(1):32-5. PubMed ID: 1370877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-human primate (baboon) anti-gross cystic disease fluid protein-15 antibody infusion in four women with metastatic breast carcinoma.
    Estabrook A; Kister SJ; Hardy MA; Grossbard L; Oster MW; Davis S; Mazoujian G; Haagensen DE
    Cancer Immunol Immunother; 1986; 23(2):143-7. PubMed ID: 3490912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review of GCDFP-15. An apocrine marker protein.
    Haagensen DE; Dilley WG; Mazoujian G; Wells SA
    Ann N Y Acad Sci; 1990; 586():161-73. PubMed ID: 2192632
    [No Abstract]   [Full Text] [Related]  

  • 34. Alpha-lactalbumin and GCDFP-15 as breast tumor markers (an opportunity to study breast tumors functionally).
    Collette J; Van Cauwenberge JR; Le Doussal V; Serilas M; Hustin J; Carlisi A; Dejardin L; Franchimont P
    Int J Rad Appl Instrum B; 1987; 14(4):385-95. PubMed ID: 3654256
    [No Abstract]   [Full Text] [Related]  

  • 35. Relation between apocrine differentiation and receptor status, prognosis and hormonal response in breast cancer.
    Bundred NJ; Stewart HJ; Shaw DA; Forrest AP; Miller WR
    Eur J Cancer; 1990; 26(11-12):1145-7. PubMed ID: 2149996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hormonal regulation of GCDFP-15 secretion in breast tumors. Study of cultured cells].
    Boutteville C; Revillion F; Vandewalle B; Lefèbvre J
    Bull Cancer; 1989; 76(8):805-11. PubMed ID: 2620105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic clearance and metabolism in the rat of a human breast cancer associated glycoprotein (GCDFP-15).
    Toth CA; Haagensen DE; Davis S; Zamcheck N; Thomas P
    Breast Cancer Res Treat; 1988 Oct; 12(2):235-43. PubMed ID: 3242652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast gross cystic disease protein 15 in human breast cancer in culture.
    Miller WR; Shivas AA; Franchimont P; Haagensen DE
    Eur J Cancer Clin Oncol; 1988 Feb; 24(2):223-8. PubMed ID: 3356211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Symposium: New markers in hormone-dependent cancers].
    Ann Endocrinol (Paris); 1985; 46(4-5):325-41. PubMed ID: 3837633
    [No Abstract]   [Full Text] [Related]  

  • 40. Usefulness of clinical chemistry measurements in classifying patients with breast cancer.
    Statland BE; Winkel P
    Crit Rev Clin Lab Sci; 1982; 16(4):255-90. PubMed ID: 6749428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.